Truly Brief Communications

The Journal of Brief Ideas, a platform that publishes 200-word articles, launches in beta.

Written byDalmeet Singh Chawla
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, THEREALDAVIDFRANCISPhysicist David Harris finds the current convention of scientific publishing—in which researchers conduct experiments in private before making their novel ideas public—inefficient. So he developed a platform that enables researchers to publish their ideas online in real time, making them immediately available for public scrutiny. The Journal of Brief Ideas, which launched in beta this month, is a citable online index of research articles that are 200 words or fewer.

Similar to preprints, non-peer-reviewed articles that are published online, articles published in Brief Ideas do not necessarily resemble the traditional publication format. There’s no need to include materials and methods, for example. An author might choose to submit only a research proposal of sorts.

“There is intellectual capital locked up in the heads of scientists rather than circulating in the scientific community,” said Harris. As a result, he added, “people often get similar ideas around about the same time, frantically work on it for quite a long time, put a lot of resources into it, without even necessarily knowing if there are other people doing the exact same thing.”

Because their submissions will be searchable, time-stamped, and open-access, authors can easily claim credit for their ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies